|Articles|April 13, 2022
Streamlining DAR Determination for ADCs
Author(s)Agilent
Automated Antibody Drug Conjugate (ADC) purification and deglycosylation increases reproducibility and simplifies drug-to-antibody ratio (DAR) determination.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
5
